Fe 3 O 4 @Bi 2 S 3 Nanoparticles Mediated MRI-Guided Precision Radiosensitization for Orthotopic Glioblastoma via External Magnetism
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c01498 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Xiaowei Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Institute of Translational Medicine, Anhui Medic…. Hauptthemen laut MEDLINE: Glioblastoma, Radiation-Sensitizing Agents, Bismuth, Sulfides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Radioresistance in tumors and the excess damage in normal tissues during radiotherapy (RT) restrict the clinical application of glioblastoma RT. Image-guided radiosensitization is hopefully adopted to achieve precision RT. Nevertheless, the therapeutic effect of radiosensitizers in glioblastoma is unsatisfactory due to limitations of the blood-brain barrier and poor tumor targeting. Herein, Fe3O4@Bi2S3 nanoparticles coated with a glioblastoma cell membrane (denoted as FBM) have been designed to sensitize RT. FBM accumulates precisely within the tumors via external magnetism and homologous adhesion capability. Afterward, FBM releases high-Z atoms (Bismuth) in ionizing radiation and tumor micro acidic environments that interact with ionizing radiation to generate high densities of secondary radiation, which leads to enhanced radiation dose deposits. Simultaneously, FBM generates reactive oxygen species, accumulates lipid peroxidation and Fe2+, depletes glutathione, and downregulates glutathione peroxidase 4 to activate ferroptosis. Notably, the tumor growth inhibition rate of FBM-mediated RT via external magnetism increases to 75.49% in the orthotopic glioblastoma model. Besides, FBM with magnetic resonance imaging performance shows the potential application in tumor diagnosis and therapy surveillance, thereby reducing damage to adjacent normal tissues and realizing MRI-guided precision RT. Hence, the novel multifunctional nanoplatform offers the potential for image-guided radiosensitization induced by activating ferroptosis, thus presenting an efficient radiotherapeutic approach for glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, Anhui 230022, P. R. China.
- Research Center of Clinical Medical Imaging, Hefei, Anhui 230022, P. R. China.
- Department of Radiotherapy, Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230036, P. R. China.
- School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230011, P. R. China.
ORCID-Profile: Haisheng Qian
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, X., Xiao, L., Xu, L., Jiang, Y., Fu, W., Chen, B., Zheng, W., Qian, H., & Yu, Y. (2025). Fe 3 O 4 @Bi 2 S 3 Nanoparticles Mediated MRI-Guided Precision Radiosensitization for Orthotopic Glioblastoma via External Magnetism. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c01498
Vancouver
Song X, Xiao L, Xu L, Jiang Y, Fu W, Chen B, et al. Fe 3 O 4 @Bi 2 S 3 Nanoparticles Mediated MRI-Guided Precision Radiosensitization for Orthotopic Glioblastoma via External Magnetism. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c01498
BibTeX
@article{Song2025,
author = {Song, Xiaowei and Xiao, Liang and Xu, Lingling and Jiang, Yechun and Fu, Wanyue and Chen, Benjin and Zheng, Wang and Qian, Haisheng and Yu, Yongqiang},
title = {Fe 3 O 4 @Bi 2 S 3 Nanoparticles Mediated MRI-Guided Precision Radiosensitization for Orthotopic Glioblastoma via External Magnetism},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c01498}
}
EUVIMED